Anna K. Lugnér

902 total citations
26 papers, 677 citations indexed

About

Anna K. Lugnér is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Anna K. Lugnér has authored 26 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 10 papers in Infectious Diseases and 6 papers in Health. Recurrent topics in Anna K. Lugnér's work include Influenza Virus Research Studies (6 papers), Vaccine Coverage and Hesitancy (6 papers) and COVID-19 epidemiological studies (5 papers). Anna K. Lugnér is often cited by papers focused on Influenza Virus Research Studies (6 papers), Vaccine Coverage and Hesitancy (6 papers) and COVID-19 epidemiological studies (5 papers). Anna K. Lugnér collaborates with scholars based in Netherlands, United States and Spain. Anna K. Lugnér's co-authors include Jacco Wallinga, Sido D. Mylius, Paul F. M. Krabbe, Maarten J. Postma, Thomas J. Hagenaars, Anita Suijkerbuijk, Wilfrid van Pelt, Michiel van Boven, G. Ardine de Wit and Cees C. van den Wijngaard and has published in prestigious journals such as PLoS ONE, BMJ and Emerging infectious diseases.

In The Last Decade

Anna K. Lugnér

26 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna K. Lugnér Netherlands 18 311 234 154 120 115 26 677
Salah Al Awaidy Oman 17 360 1.2× 407 1.7× 100 0.6× 218 1.8× 61 0.5× 89 900
Ann E. Wiringa United States 16 317 1.0× 247 1.1× 158 1.0× 203 1.7× 28 0.2× 24 661
Namrata Prasad New Zealand 14 359 1.2× 240 1.0× 103 0.7× 87 0.7× 39 0.3× 35 885
Kalliopi Theodoridou Greece 14 355 1.1× 240 1.0× 68 0.4× 158 1.3× 23 0.2× 38 750
Carlos Magno Castelo Branco Fortaleza Brazil 20 295 0.9× 391 1.7× 83 0.5× 26 0.2× 51 0.4× 102 1.1k
Julia E. Aledort United States 9 282 0.9× 306 1.3× 123 0.8× 27 0.2× 51 0.4× 14 697
Paul Armstrong Australia 16 410 1.3× 376 1.6× 103 0.7× 116 1.0× 29 0.3× 40 826
Akinola Ayoola Fatiregun Nigeria 17 364 1.2× 339 1.4× 103 0.7× 251 2.1× 60 0.5× 95 1.0k
Alies van Lier Netherlands 19 737 2.4× 256 1.1× 122 0.8× 377 3.1× 33 0.3× 34 1.1k
Germaine Hanquet Belgium 16 757 2.4× 360 1.5× 90 0.6× 164 1.4× 51 0.4× 59 1.1k

Countries citing papers authored by Anna K. Lugnér

Since Specialization
Citations

This map shows the geographic impact of Anna K. Lugnér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna K. Lugnér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna K. Lugnér more than expected).

Fields of papers citing papers by Anna K. Lugnér

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna K. Lugnér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna K. Lugnér. The network helps show where Anna K. Lugnér may publish in the future.

Co-authorship network of co-authors of Anna K. Lugnér

This figure shows the co-authorship network connecting the top 25 collaborators of Anna K. Lugnér. A scholar is included among the top collaborators of Anna K. Lugnér based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna K. Lugnér. Anna K. Lugnér is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suijkerbuijk, Anita, Eelco A. B. Over, Fleur van Aar, et al.. (2017). Consequences of restricted STI testing for young heterosexuals in the Netherlands on test costs and QALY losses. Health Policy. 122(2). 198–203. 4 indexed citations
2.
Xiridou, Maria, Anna K. Lugnér, Henry J.C. de Vries, et al.. (2016). Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands. Sexually Transmitted Diseases. 43(9). 542–548. 6 indexed citations
3.
Lier, Alies van, Anna K. Lugnér, Wim Opstelten, et al.. (2015). Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster. EBioMedicine. 2(10). 1494–1499. 22 indexed citations
4.
Wijngaard, Cees C. van den, Agnetha Hofhuis, Margriet Harms, et al.. (2015). The burden of Lyme borreliosis expressed in disability-adjusted life years. European Journal of Public Health. 25(6). 1071–1078. 42 indexed citations
5.
Suijkerbuijk, Anita, Tom Woudenberg, Susan Hahné, et al.. (2015). Economic Costs of Measles Outbreak in the Netherlands, 2013–2014. Emerging infectious diseases. 21(11). 2067–2069. 21 indexed citations
6.
Enserink, Remko, Anna K. Lugnér, Anita Suijkerbuijk, et al.. (2014). Gastrointestinal and Respiratory Illness in Children That Do and Do Not Attend Child Day Care Centers: A Cost-of-Illness Study. PLoS ONE. 9(8). e104940–e104940. 39 indexed citations
7.
Vriend, Henrike J., Anna K. Lugnér, Maria Xiridou, et al.. (2013). Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective. AIDS. 27(14). 2281–2290. 14 indexed citations
8.
Xiridou, Maria, Henrike J. Vriend, Anna K. Lugnér, et al.. (2013). Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men. BMC Infectious Diseases. 13(1). 436–436. 27 indexed citations
9.
Lugnér, Anna K., Nicoline van der Maas, Michiel van Boven, Frits R. Mooi, & Hester E. de Melker. (2013). Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: Comparing neonatal, maternal, and cocooning vaccination strategies. Vaccine. 31(46). 5392–5397. 18 indexed citations
10.
Lugnér, Anna K., Michiel van Boven, Robin de Vries, Maarten J. Postma, & Jacco Wallinga. (2012). Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ. 345(jul12 3). e4445–e4445. 30 indexed citations
11.
Suijkerbuijk, Anita, Anna K. Lugnér, Wilfrid van Pelt, et al.. (2012). Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands. Vaccine. 30(35). 5199–5205. 6 indexed citations
12.
Friesema, Ingrid, et al.. (2012). Costs of gastroenteritis in the Netherlands, with special attention for severe cases. European Journal of Clinical Microbiology & Infectious Diseases. 31(8). 1895–1900. 37 indexed citations
13.
Wielders, Cornelia C. H., Arianne B. van Gageldonk‐Lafeber, Cees C. van den Wijngaard, et al.. (2010). The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. European Journal of Public Health. 22(1). 150–157. 33 indexed citations
14.
Burström, Kristina, Ann‐Charlotte Egmar, Anna K. Lugnér, Mikael Eriksson, & Magnus Svartengren. (2010). A Swedish child-friendly pilot version of the EQ-5D instrument--the development process. European Journal of Public Health. 21(2). 171–177. 38 indexed citations
15.
Lugnér, Anna K. & Maarten J. Postma. (2009). Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs. European Journal of Public Health. 19(5). 516–520. 20 indexed citations
16.
Lugnér, Anna K., Liesbeth Mollema, Wilhelmina L.M. Ruijs, & Susan Hahné. (2009). A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome. Epidemiology and Infection. 138(8). 1172–1184. 11 indexed citations
17.
Attema, Arthur E., Anna K. Lugnér, & Talitha Feenstra. (2009). Investment in antiviral drugs: a real options approach. Health Economics. 19(10). 1240–1254. 18 indexed citations
18.
Greeff, Sabine C. de, et al.. (2009). Economic analysis of pertussis illness in the Dutch population: Implications for current and future vaccination strategies. Vaccine. 27(13). 1932–1937. 22 indexed citations
19.
Altes, Hester Korthals, Frederika Dijkstra, Anna K. Lugnér, Frank Cobelens, & Jacco Wallinga. (2009). Targeted BCG Vaccination Against Severe Tuberculosis in Low-prevalence Settings. Epidemiology. 20(4). 562–568. 8 indexed citations
20.
Mylius, Sido D., Thomas J. Hagenaars, Anna K. Lugnér, & Jacco Wallinga. (2008). Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine. 26(29-30). 3742–3749. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salah Al Awaidy Breakdown of academic impact, for papers by Ann E. Wiringa Breakdown of academic impact, for papers by Namrata Prasad Breakdown of academic impact, for papers by Kalliopi Theodoridou Breakdown of academic impact, for papers by Carlos Magno Castelo Branco Fortaleza Breakdown of academic impact, for papers by Julia E. Aledort Breakdown of academic impact, for papers by Paul Armstrong Breakdown of academic impact, for papers by Akinola Ayoola Fatiregun Breakdown of academic impact, for papers by Alies van Lier Breakdown of academic impact, for papers by Germaine Hanquet
Rankless by CCL
2026